Architect Of Keytruda Reflects On A Great Scientific Success Story
As Merck Presents Yet More Data On Blockbuster At ESMO
Eric Rubin, who heads up early oncology clinical development at Merck Research Laboratories, tells Scrip that it became clear very early on that Keytruda was something special.
